[Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
作者信息
Sugimoto M, Fujimura Y, Okubo Y, Takahashi Y, Yoshioka A, Fukui H
出版信息
Nihon Ketsueki Gakkai Zasshi. 1984 Aug;47(5):1181-9.
PMID:6516702
Abstract
摘要
相似文献
1
[Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].[对一种市售凝血酶原复合物浓缩物（Proplex）中所含FIX抑制物旁路活性的分析]
Nihon Ketsueki Gakkai Zasshi. 1984 Aug;47(5):1181-9.
2
3
Treatment of hemophilia B with a new clotting-factor concentrate.用一种新型凝血因子浓缩物治疗乙型血友病。
N Engl J Med. 1969 Mar 13;280(11):581-6. doi: 10.1056/NEJM196903132801103.
4
Surgical operation in hemophilia B. Use of factor IX concentrate.乙型血友病的外科手术。IX因子浓缩物的应用。
Calif Med. 1970 Jul;113(1):4-8.
5
Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.一名患有因子IX抑制剂的B型血友病患者在接受FEIBA治疗后发生心肌梗死。
Ann Hematol. 1992 Jun;64(6):309-11. doi: 10.1007/BF01695478.
6
Monoclonal antibody-purified factor IX--comparative thrombogenicity to prothrombin complex concentrate.单克隆抗体纯化的凝血因子IX——与凝血酶原复合物浓缩物的血栓形成性比较
Semin Hematol. 1991 Jul;28(3 Suppl 6):15-9.
7
8
[Coagulation factor IX inhibitor in hemophilia B].[血友病B中的凝血因子IX抑制剂]
Z Med Lab Diagn. 1990;31(2):113-9.
9
Surgery in haemophilic patients with inhibitors.伴有抑制物的血友病患者的手术治疗
Haemophilia. 2004 Sep;10 Suppl 2:1-2. doi: 10.1111/j.1365-2516.2004.00933.x.
10
[Use of proplex in a hemophilia B patient].[凝血酶原复合物在一名乙型血友病患者中的应用]
Rinsho Ketsueki. 1984 Aug;25(8):1299-305.
Zotero 插件